z-logo
open-access-imgOpen Access
Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence
Author(s) -
Kevin W. Garey,
Warren E. Rose,
Kyle Gunter,
Alisa W. Serio,
Mark H. Wilcox
Publication year - 2022
Publication title -
annals of pharmacotherapy/the annals of pharmacotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.926
H-Index - 113
eISSN - 1542-6270
pISSN - 1060-0280
DOI - 10.1177/10600280221089007
Subject(s) - medicine , clostridioides , clostridium difficile , adverse effect , antibiotics , microbiology and biotechnology , biology
The objective of this systematic review is to summarize in vitro, preclinical, and human data related to omadacycline and Clostridioides difficile infection (CDI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here